Roger Song
Senior Equity Research Analyst Jefferies
Roger has ~20 years of experience in life sciences across equity research, strategy consulting, private equity/ venture capital, product marketing and sales management. He is also a physician by training. He holds an MBA with Health Sector Management certificate from Duke University, and an MD from Fudan University. He is also a CFA charterholder.
Seminars
Thursday 31st July 2025
Investment Panel: Attracting Investment & Securing Preclinical Funding for Early-Stage RNA Editing Therapeutic Candidates
9:00 am
• How is RNA editing viewed by investors and what are the directions for growth?
• How to successfully gain funding for preclinical candidates by demonstrating the right data
• What are the hurdles and pitfalls to starting an RNA Editing therapeutics company and what are the timelines, collaborations, and levels of investment required
